Skip to main content
. 2021 Jun 15;10(3):581–599. doi: 10.1007/s40123-021-00357-y

Fig. 3.

Fig. 3

Percentage change of MMP-9 biomarker presence—LCD vs. placebo (a right eye; b left eye). A significant reduction in the number of subjects with MMP-9 biomarker-positive results for tear inflammation was observed on day 56 for the LCD group compared to the placebo group. P < 0.05. **Statistically significant, P < 0.01